Anika Therapeutics Reports 1Q18 Orthobiologic Revenue

By Julie A. Vetalice

Anika Therapeutics posted 1Q18 orthobiologic revenue of US $19.5MM, -3.6% vs. 1Q17.

Member-Only Content

SUBSCRIBE Login

Product Labels: Viscosupplement

Tags: Revenue Report